News

RTP Oncology Firm reports good news for pancreatic cancer patients
Physicians at VCU Massey Cancer Center in Richmond, VA are the first in the world to successfully implant a new bio-absorbable, internal radiation treatment known as CivaSheet to treat a patient with resectable pancreatic cancer. Approximately 53,000 patients per year in the US are diagnosed with pancreatic cancer, and of those, approximately 13,00 will undergo surgical resection…
Initial Clinical Experience with Uni-Directional LDR Brachytherapy in the Treatment of Retroperitoneal Sarcoma
CivaTech Oncology INC. Awarded Up TO $2.3M from NIH for pancreatic Cancer Study with CIvaSheet Device
Two Year Quality of Life Follow up on CivaString Line Source for Prostate Brachytherapy reporting minimal side effects
First Report of the Implantable Uni-Directional Planar LDR Brachytherapy for Patients with Locally Advanced Pancreatic Cancer; Widening the Therapeutic Window using an Implantable, Uni-directional LDR Brachytherapy Sheet as a Boost in Pancreatic Cancer
Physicians are now able to successfully implant a new bio-absorbable, internal radiation treatment known as CIvaSheet to treat a patient with recurrent lung cancer. Approximately 234,000 patients per year in the U.S. are diagnosed with lung cancer, and of those, approximately 30% to 55% of patients with non-small cell lung cancer develop recurrence. 

​©2019 CivaTech Oncology Inc. All Rights Reserved